GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Float Percentage Of Total Shares Outstanding

Trinity Biotech (Trinity Biotech) Float Percentage Of Total Shares Outstanding : 61.59% (As of Apr. 28, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Trinity Biotech's float shares is 4.71 Mil. Trinity Biotech's total shares outstanding is 7.64 Mil. Trinity Biotech's float percentage of total shares outstanding is 61.59%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Trinity Biotech's Insider Ownership is 5.77%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Trinity Biotech's Institutional Ownership is 0.01%.

Trinity Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Trinity Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=4.71/7.64
=61.59%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trinity Biotech (Trinity Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (NAS:TRIB) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TTOO PMD STRR CHEK SLDX CNTG MYNZ PRPO BIAF XWEL TSE:2309 TMO DHR IQV IDXX XSWX:LONN A MTD ICLR ILMN
Traded in Other Exchanges
TRBA:Germany
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Website
https://www.trinitybiotech.com
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.